Member Info for Soupdragon78

Oh dear older, just because nothing apparently happened with the millennium bug doesn’t mean there wasn’t a huge effort that went into mitigating the problem. There was a massive industry and millions that went into resolving the problem, the fact that there were only a few issue is testament to the work that went into the problem.

Just because you didn’t see it doesn’t mean it wasn’t a problem.

I hope you are willing to explain to any of your family who could end up in hospital with COVID that it isn’t actually a problem and you think they are putting it on. I somehow think you wouldn’t be as brave as when hiding behind a keyboard.

JD the point I’m making is that you originally said that people should just let it pass.

What I’m pointing out is that the current levels of fatalities are low precisely because action was taken. If nothing was done as you are advocating the. It would be massively worse.

As I said, doing nothing is not an option.

JD, that’s because governments have acted hence mitigating the problem. What you were saying is do nothing, which would lead to a massive problem.

Doing nothing is not a solution

See page 6
https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf

Closing the markets would be a sensible move as they serve no purpose in situation like this.

JD, its not whats happened so far, its what is yet to come. If we do nothing then the current predictions (see Imperial College report released this morning) mean it will peak in May with circa 300,000 deaths in the UK.

Or we could act like Japan has done which has kept it at low level.

And the pointless rant of the day winner is....

Infor, so your hoping for no news till later in the year then?

Not even going to pretend to figure out today’s trades, really weird that two massive buys have little effect and somehow someone can get 100k at spot on mid price which no one else has achieved.

Seems the polar opposite of recent days where any volume in either direction has an immediate impact.

Well, someone seems happy buying 450k shares here at 5.5p

They're just doing what they're supposed to do, making a market.

If they have sellers they need to attract buyers and vice versa.

Whitney, we know that is a possibility. Its still early days in both the COVID-19 episode and also NFX development and testing of NXP002.
I think this will another string to their bow, but I don't see it in the short term, it'll be beneficial to those who suffer long term effects.

The 100k+ trades still weighing this down, but at 4.6p to buy it would be rude not to. Just added 23,500 and will ride out the storm.

Price monitoring extensions happen when they can’t match up at the end of an auction. No big deal, you can see it coming on level 2.

Goup, don't think we have any, but I'll quite happily do so for a fee.

Not really within the scope of what NFX do.

NFX primarily seek to build upon existing drugs using cocrystal tech to improve or alter their performance. They're not in the business of rapid response.

Also looking for news on NXP001 deal with a global generics company. That will provide a good base for NXP002.

Still feels like a background seller despite the price movement earlier this week. Ask being walked down with each buy.

Waiting game at the moment.

Certainly odd sp movement or non-movement through the day. Bounced around within the spread then dipped.

Just been trying to dig around the CBD Cannabinoid side of things without much luck. Although I did come across this small San Diego company ($4m mcap) who have a patent on CDB Cocrystal. They are targeting the PTSD and IBD markets. See page 18 onwards.
Interesting are the two blockbuster cocrystal drugs they identify. Entrestro by Novartis which has sales of circa $1bn p.a. and Lexapro by ForestLabs which has sales of over $2bn p.a.

https://d1io3yog0oux5.cloudfront.net/_546e1497b0d9c30cc42582712166a807/artelobio/db/776/6602/pdf/Artelo+Bio+-+13FEB2020.pdf

Get the feeling sells will come through with any rise or increased buying, at least they do seem to want to keep an orderly market.

On the patent side its quite fascinating to see that NFX have managed to make tranilast soluble, so it can be mixed with water just prior to application.

From what I can gather, tranilast (also known as Rizaben) has sales of about $120m a year and this seems to be a significant improvement on its properties. No wonder the company is confident.